Client Alerts & Insights
Back in Action—New March Deadline to Comply with CTA’s BOI Reporting Requirements
February 20, 2025
As of the February 18, 2025, decision by the U.S. District Court for the Eastern District of Texas in Smith v. U.S. Department of the Treasury, et al., 6:24-cv-00336 (E.D. Tex.), beneficial ownership information (BOI) reporting requirements under the Corporate Transparency Act (CTA) are once again back in effect.
This comes as the latest in a line of decisions pausing and unpausing the reporting requirements which were set to go into effect at the start of the year. In early December, the U.S. District Court for the Eastern District of Texas issued a nationwide preliminary injunction blocking the U.S. Department of Treasury from enforcing the CTA’s BOI reporting requirements. Then in late December, a motions panel of the Fifth Circuit Court of Appeals stayed the preliminary injunction, restoring the reporting requirements. Since then, the Fifth Circuit reinstated the injunction and then the Supreme Court nixed it.
On the heels of this latest decision, FinCEN has extended the deadline for most companies to file their initial, updated or corrected BOI report to March 21, 2025.
The future of the CTA remains uncertain, and reporting entities should work with experienced counsel to prepare to file by the new March 21 deadline. If you have questions regarding the CTA or your BOI reporting obligations, the White Collar and Corporate & Securities Practice Groups at Benesch are here to help.
Marisa T. Darden at mdarden@beneschlaw.com or 216.363.4440.
Jennifer L. Stapleton at jstapleton@beneschlaw.com or 216.363.4428.
Connie A. Porter at cporter@beneschlaw.com or 216.363.4433.
Robert J. Kolansky at rkolansky@beneschlaw.com or 216.363.4575.
Latest News
CMS Proposes Sweeping Restrictions on Remote Patient Monitoring: The Outsourcing Ban, Reimbursement Revaluation and Potential Code Consolidation in the CY 2027 Physician Fee Schedule Proposed Rule
CMS’s CY 2027 Proposed Rule would significantly restrict Medicare reimbursement for Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM), including banning outsourced clinical staffing, adding new patient-relationship and initiating-visit requirements, reducing certain reimbursement rates, and exploring consolidation of existing billing codes.
Canada Trade – New Tariff Announcement and USMCA Non-Renewable Stakes for North American Supply Chains
On July 20, 2026, the Trump Administration announced a new set of sweeping tariffs on Canadian goods. This comes less than one month after the United States decided against renewing the free trade agreement between the United States of America, Mexico, and Canada (the “USMCA”) during the required six-year joint review.
Colorado Enacts Comprehensive Licensing Requirements for Applied Behavior Analysis Practitioners and Clinics
Key Takeaways On June 2, 2026, Colorado’s governor signed House Bill 26-1425 into law, establishing the Applied Behavior Analysis Practice …
Section 301 Duties for Forced Labor – Step 3 in IEEPA Replacement and its Impact
The White House initiated its third step in replacing IEEPA tariffs on Friday, July 24. Specifically, the U.S. Trade Representative (“USTR”) published final Section 301 findings and duty rates for imports from 30 countries following its investigation of harms on the domestic industry due to forced labor in those countries’ supply chains.